COMPASS-CAT: a risk assessment model for cancer-related VTE in breast, colorectal, lung and ovarian cancer32
| Patient characteristic | Score |
| Cancer-related risk factors | |
| Antihormonal therapy or anthracycline | 6 |
| Time since cancer diagnosis ≤6 months | 4 |
| CVC | 3 |
| Advanced stage of cancer | 2 |
| Predisposing risk factors | |
| Cardiovascular risk factors (at least 2 of the following predictors: a personal history of peripheral artery disease, ischaemic stroke, coronary artery disease, hypertension, hyperlipidaemia, diabetes, obesity) | 5 |
| Recent hospitalisation for acute medical illness | 5 |
| Personal history of VTE | 1 |
| Biomarkers | |
| Platelet count ≥350×109/L | 2 |
CVC, central venous catheter; VTE, venous thromboembolism.